{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:31:08Z","timestamp":1786681868793,"version":"build-2736575974"},"reference-count":183,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gout, Hyperuricemia and Crystal-Associated Disease Network"},{"name":"UAB Presidential Office Bridge Award"},{"DOI":"10.13039\/501100011033","name":"Spanish State Research Agency","doi-asserted-by":"crossref","award":["PID2025-169543OB-I00"],"award-info":[{"award-number":["PID2025-169543OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioengineering"],"abstract":"<jats:p>Mouse models have been indispensable for defining the mechanisms of atherosclerosis, yet no single model reproduces the full spectrum of human disease. This review provides a practical framework for selecting mouse models according to the biological question being addressed. We compare classical lipoprotein-driven models, including Apoe\u2212\/\u2212 and Ldlr\u2212\/\u2212 mice, with models designed to study human-like lipoprotein metabolism, immune and immunometabolic mechanisms, adult-onset hypercholesterolemia, plaque complexity, coronary disease, and myocardial infarction-like outcomes. Particular emphasis is placed on how genetic background, lipoprotein composition, diet, sex, age, vascular site, and experimental design shape lesion development and influence interpretation. We also discuss discrepancies across single-cell RNA-sequencing studies, highlighting how differences in model, tissue processing, disease stage, and analytical strategy can alter the macrophage and immune-cell states detected. Rather than ranking models, we define what each model can teach, what it may miss, and when it is most appropriate to use. We conclude that future progress will depend on question-driven model selection, cross-model validation, improved reporting, and greater integration of molecular, spatial, and human benchmarking approaches.<\/jats:p>","DOI":"10.3390\/bioengineering13080911","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:11:36Z","timestamp":1786525896000},"page":"911","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mouse Models of Atherosclerosis: What They Teach Us, What They Miss, and When to Use Them"],"prefix":"10.3390","volume":"13","author":[{"given":"Xiaoxiao","family":"Geng","sequence":"first","affiliation":[{"name":"Division of Clinical Immunology & Rheumatology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisse R.","family":"McKee","sequence":"additional","affiliation":[{"name":"Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2169-3972","authenticated-orcid":false,"given":"Manuel","family":"Rosa-Garrido","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Signaling, The Institute of Biomedicine and Biotechnology of Cantabria, CSIC-University of Cantabria, 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidoro","family":"Cobo","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology & Rheumatology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"Department of Biomedical Engineering, School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"Comprehensive Arthritis, Musculoskeletal, Bone and Autoimmunity Center (CAMBAC), The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Verboova, L., Nedoroscik, A., Kiskova-Simkova, T., Smirjakova, A., Bohus, P., Kollar, M., Virag, M., Mazarova, K., and Zavacka, M. (2026). Atherosclerosis: A Pathologist\u2019s Perspective. J. Cardiovasc. Dev. Dis., 13.","DOI":"10.3390\/jcdd13020085"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Araujo, G., Valencia, L.M., Martin-Ozimek, A., Soto, Y., and Proctor, S.D. (2025). Atherosclerosis: From lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1485801"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107833","DOI":"10.1016\/j.phrs.2025.107833","article-title":"VSMCs in atherosclerosis: Implications on the role of inflammation and extracellular matrix remodelling","volume":"218","author":"Jarad","year":"2025","journal-title":"Pharmacol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Di Nubila, A., Dilella, G., Simone, R., and Barbieri, S.S. (2024). Vascular Extracellular Matrix in Atherosclerosis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212017"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1161\/ATVBAHA.117.309229","article-title":"Cell Death in the Vessel Wall: The Good, the Bad, the Ugly","volume":"37","author":"Rayner","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/CIRCRESAHA.120.316903","article-title":"Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas","volume":"127","author":"Zernecke","year":"2020","journal-title":"Circ. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and inflammatory mechanisms of atherosclerosis","volume":"27","author":"Galkina","year":"2009","journal-title":"Annu Rev. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and Inflammation in Atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","article-title":"How the immune system shapes atherosclerosis: Roles of innate and adaptive immunity","volume":"22","author":"Roy","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_12","first-page":"e230017","article-title":"Atherosclerosis: An overview of mouse models and a detailed methodology to quantify lesions in the aortic root","volume":"6","author":"Rensen","year":"2024","journal-title":"Vasc. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/MOL.0000000000000843","article-title":"Early atherogenesis: New insights from new approaches","volume":"33","author":"Scipione","year":"2022","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: Metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lorey, M.B., Oorni, K., and Kovanen, P.T. (2022). Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.841545"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"12807","DOI":"10.3390\/ijms150712807","article-title":"Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease","volume":"15","author":"Orekhov","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/HYPERTENSIONAHA.107.089854","article-title":"Effects of native and modified low-density lipoproteins on monocyte recruitment in atherosclerosis","volume":"50","author":"Gleissner","year":"2007","journal-title":"Hypertension"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Oppi, S., Luscher, T.F., and Stein, S. (2019). Mouse Models for Atherosclerosis Research-Which Is My Line? . Front. Cardiovasc. Med., 6.","DOI":"10.3389\/fcvm.2019.00046"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Alonso-Herranz, L., Albarran-Juarez, J., and Bentzon, J.F. (2023). Mechanisms of fibrous cap formation in atherosclerosis. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1254114"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0008-6363(98)00286-7","article-title":"Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation","volume":"41","author":"Newby","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/ATVBAHA.107.159327","article-title":"Role of smooth muscle cells in the initiation and early progression of atherosclerosis","volume":"28","author":"Doran","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e37727","DOI":"10.1016\/j.heliyon.2024.e37727","article-title":"Vascular smooth muscle cell phenotypic switching in atherosclerosis","volume":"10","author":"Yu","year":"2024","journal-title":"Heliyon"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular Smooth Muscle Cells in Atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1161\/CIRCULATIONAHA.120.049922","article-title":"Fate and State of Vascular Smooth Muscle Cells in Atherosclerosis","volume":"143","author":"Miano","year":"2021","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Yan, F., Sun, S.Y., and Wu, H. (2025). The \u201cangiogenesis-plaque stability paradox\u201d in atherosclerosis pathogenesis. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1659006"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jacasi.2026.01.002","article-title":"Cholesterol-Inflammation Fusion Hypothesis in Atherosclerosis: An Evolving Paradigm in Pathogenesis and Therapy","volume":"6","author":"Zeng","year":"2026","journal-title":"JACC Asia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9811","DOI":"10.2147\/JIR.S531345","article-title":"Atherosclerosis and Inflammation: Are the Rules of the Game Changing with Biological Therapies?","volume":"18","author":"Bora","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/annrheumdis-2016-210426","article-title":"CCL2\/CCR2, but not CCL5\/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis","volume":"76","author":"Raghu","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00384-016-2735-y","article-title":"Downregulation of CX(3)CR1 ameliorates experimental colitis: Evidence for CX(3)CL1-CX(3)CR1-mediated immune cell recruitment","volume":"32","author":"Becker","year":"2017","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/cvr\/cvad130","article-title":"Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis: Drug discovery and development of vascular cell adhesion molecule-1-directed novel therapeutics","volume":"119","author":"Pickett","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCRESAHA.115.306256","article-title":"Macrophage Phenotype and Function in Different Stages of Atherosclerosis","volume":"118","author":"Tabas","year":"2016","journal-title":"Circ. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: A dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Chen, J., Xiang, X., Nie, L., Guo, X., Zhang, F., Wen, C., Xia, Y., and Mao, L. (2022). The emerging role of Th1 cells in atherosclerosis and its implications for therapy. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1079668"},{"key":"ref_34","first-page":"2","article-title":"Regulatory T cells and Atherosclerosis","volume":"2012","author":"Pastrana","year":"2012","journal-title":"J. Clin. Exp. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Reijnders, E., van der Laarse, A., Jukema, J.W., and Cobbaert, C.M. (2023). High residual cardiovascular risk after lipid-lowering: Prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1264319"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ehjqcco\/qcz055","article-title":"Residual inflammatory risk after contemporary lipid lowering therapy","volume":"6","author":"Riaz","year":"2020","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis\u2014From experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Libby, P. (2021). Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond. Cells, 10.","DOI":"10.3390\/cells10040951"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.tibs.2024.06.003","article-title":"Immunometabolism in atherosclerosis: A new understanding of an old disease","volume":"49","author":"Certo","year":"2024","journal-title":"Trends Biochem. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","article-title":"Metabolic regulation of the immune system in health and diseases: Mechanisms and interventions","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12944-016-0402-5","article-title":"Mouse models of atherosclerosis: A historical perspective and recent advances","volume":"16","author":"Lee","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/ATVBAHA.111.237693","article-title":"Animal models of atherosclerosis","volume":"32","author":"Getz","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cmet.2016.11.001","article-title":"Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis","volume":"25","author":"Zhao","year":"2017","journal-title":"Cell Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1126\/science.272.5262.685","article-title":"Mouse models of atherosclerosis","volume":"272","author":"Breslow","year":"1996","journal-title":"Science"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI116663","article-title":"Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery","volume":"92","author":"Ishibashi","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Basu, D., and Bornfeldt, K.E. (2020). Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00504"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2174\/138945008783755629","article-title":"Lipoprotein size and susceptibility to atherosclerosis--insights from genetically modified mouse models","volume":"9","author":"Veniant","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/ATVBAHA.116.306874","article-title":"Do the Apoe-\/- and Ldlr-\/- Mice Yield the Same Insight on Atherogenesis?","volume":"36","author":"Getz","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Ramirez, C., Sierra, S., Tercero, I., Vazquez, J.A., Pineda, A., Manrique, T., and Burgos, J.S. (2011). ApoB100\/LDLR-\/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damage. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022712"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1038\/s41598-018-23631-9","article-title":"Low testosterone in ApoE\/LDL receptor double-knockout mice is associated with rarefied testicular capillaries together with fewer and smaller Leydig cells","volume":"8","author":"Steinfeld","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nm0898-934","article-title":"A mouse model of human familial hypercholesterolemia: Markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet","volume":"4","author":"Veniant","year":"1998","journal-title":"Nat. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e9557","DOI":"10.1590\/1414-431x20209557","article-title":"Animal models of human atherosclerosis: Current progress","volume":"53","author":"Poznyak","year":"2020","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/ATVBAHA.118.311221","article-title":"Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research","volume":"38","author":"Jarrett","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/ATVBAHA.125.321011","article-title":"Atherosclerotic Plaque Instability and Rupture: Recommended Mouse Models to Empower Clinically Relevant Discoveries, Diagnostics, and Therapeutics","volume":"45","author":"Noonan","year":"2025","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00395-020-00829-5","article-title":"Mouse models of atherosclerosis and their suitability for the study of myocardial infarction","volume":"115","author":"Golforoush","year":"2020","journal-title":"Basic Res. Cardiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/138945008783755566","article-title":"Myocardial infarction following atherosclerosis in murine models","volume":"9","author":"Braun","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1161\/CIRCRESAHA.125.326409","article-title":"Novel Mouse Model of Coronary Atherosclerosis with Myocardial Infarction: Insights into Human CAD","volume":"137","author":"Chen","year":"2025","journal-title":"Circ. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0022-2275(20)39866-7","article-title":"Transgenic mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normolipidemic humans","volume":"36","author":"Grass","year":"1995","journal-title":"J. Lipid Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/ATVBAHA.107.142570","article-title":"Mouse models for atherosclerosis and pharmaceutical modifiers","volume":"27","author":"Zadelaar","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2009.02.038","article-title":"Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice","volume":"206","author":"Zadelaar","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/CIRCRESAHA.114.302937","article-title":"Induction of atherosclerosis in mice and hamsters without germline genetic engineering","volume":"114","author":"Bjorklund","year":"2014","journal-title":"Circ. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1021\/acs.jproteome.5b00213","article-title":"A comparison of the mouse and human lipoproteome: Suitability of the mouse model for studies of human lipoproteins","volume":"14","author":"Gordon","year":"2015","journal-title":"J. Proteome Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Kotsovilis, S., Salagianni, M., Varela, A., Davos, C.H., Galani, I.E., and Andreakos, E. (2024). Comprehensive Analysis of 1-Year-Old Female Apolipoprotein E-Deficient Mice Reveals Advanced Atherosclerosis with Vulnerable Plaque Characteristics. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021355"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12035-025-05629-3","article-title":"APOE Lipoprotein Particles: Pathophysiology, Therapy, and the Crosstalk in Alzheimer\u2019s Disease and Cardiovascular Disease","volume":"63","author":"Liu","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Getz, G.S., and Reardon, C.A. (2018). Apoprotein E and Reverse Cholesterol Transport. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113479"},{"key":"ref_68","first-page":"3236","article-title":"Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice","volume":"119","author":"Stanford","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2008.11.031","article-title":"Progression of atherosclerosis in the Apo E-\/- model: 12-month exposure to cigarette mainstream smoke combined with high-cholesterol\/fat diet","volume":"205","author":"Lebrun","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Torikai, H., Chen, M.H., Jin, L., He, J., Angle, J.F., and Shi, W. (2023). Atherogenesis in Apoe-\/- and Ldlr-\/- Mice with a Genetically Resistant Background. Cells, 12.","DOI":"10.3390\/cells12091255"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1194\/jlr.R067249","article-title":"ApoE knockout and knockin mice: The history of their contribution to the understanding of atherogenesis","volume":"57","author":"Getz","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1423-0127-19-22","article-title":"Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse","volume":"19","author":"Vasquez","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1172\/JCI57559","article-title":"ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice","volume":"121","author":"Murphy","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1006\/bbrc.2001.4611","article-title":"Apolipoprotein E in macrophages and hepatocytes is eegraded via the proteasomal pathway","volume":"282","author":"Wenner","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"113206","DOI":"10.1016\/j.celrep.2023.113206","article-title":"ApoE enhances mitochondrial metabolism via microRNA-142a\/146a-regulated circuits that suppress hematopoiesis and inflammation in hyperlipidemia","volume":"42","author":"Phu","year":"2023","journal-title":"Cell Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/ATVBAHA.111.222745","article-title":"Apolipoprotein E induces antiinflammatory phenotype in macrophages","volume":"31","author":"Baitsch","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopsych.2017.03.003","article-title":"Apolipoprotein E, Receptors, and Modulation of Alzheimer\u2019s Disease","volume":"83","author":"Zhao","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"C586","DOI":"10.1152\/ajpcell.00210.2004","article-title":"ApoE-mediated cholesterol efflux from macrophages: Separation of autocrine and paracrine effects","volume":"288","author":"Dove","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0022-2275(20)33407-6","article-title":"Apolipoprotein E-dependent cholesterol efflux from macrophages: Kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E","volume":"40","author":"Lin","year":"1999","journal-title":"J. Lipid Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"110696","DOI":"10.1016\/j.cellsig.2023.110696","article-title":"Apoe-knockout induces strong vascular oxidative stress and significant changes in the gene expression profile related to the pathways implicated in redox, inflammation, and endothelial function","volume":"108","author":"Liu","year":"2023","journal-title":"Cell. Signal."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Pauli, J., Reisenauer, T., Winski, G., Sachs, N., Chernogubova, E., Freytag, H., Otto, C., Reeps, C., Eckstein, H.H., and Scholz, C.J. (2023). Apolipoprotein E (ApoE) Rescues the Contractile Smooth Muscle Cell Phenotype in Popliteal Artery Aneurysm Disease. Biomolecules, 13.","DOI":"10.3390\/biom13071074"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.112.196667","article-title":"Apolipoprotein E enhances endothelial-NO production by modulating caveolin 1 interaction with endothelial NO synthase","volume":"60","author":"Yue","year":"2012","journal-title":"Hypertension"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1074\/jbc.272.1.89","article-title":"Apolipoprotein E inhibits platelet aggregation through the L-arginine:Nitric oxide pathway. Implications for vascular disease","volume":"272","author":"Riddell","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1515\/CCLM.2005.085","article-title":"Understanding hyperlipidemia and atherosclerosis: Lessons from genetically modified apoe and ldlr mice","volume":"43","author":"Wouters","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.ATV.0000128849.12617.f4","article-title":"Atherosclerosis in the apolipoprotein-E-deficient mouse: A decade of progress","volume":"24","author":"Meir","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1161\/ATVBAHA.118.310802","article-title":"Acute Loss of Apolipoprotein E Triggers an Autoimmune Response That Accelerates Atherosclerosis","volume":"38","author":"Centa","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI8623","article-title":"The role of the LDL receptor in apolipoprotein B secretion","volume":"105","author":"Twisk","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.ATV.0000201071.49029.17","article-title":"Diet and murine atherosclerosis","volume":"26","author":"Getz","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.117.312513","article-title":"Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry","volume":"122","author":"Winkels","year":"2018","journal-title":"Circ. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCRESAHA.117.312509","article-title":"Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis","volume":"122","author":"Cochain","year":"2018","journal-title":"Circ. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1161\/01.RES.86.10.1078","article-title":"Determinants of atherosclerosis susceptibility in the C3H and C57BL\/6 mouse model: Evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism","volume":"86","author":"Shi","year":"2000","journal-title":"Circ. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1161\/ATVBAHA.107.148106","article-title":"Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice","volume":"27","author":"Wang","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1534\/genetics.105.051912","article-title":"Quantitative trait locus analysis of atherosclerosis in an intercross between C57BL\/6 and C3H mice carrying the mutant apolipoprotein E gene","volume":"172","author":"Su","year":"2006","journal-title":"Genetics"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/01.ATV.19.8.1960","article-title":"Genetic background determines the extent of atherosclerosis in ApoE-deficient mice","volume":"19","author":"Dansky","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bbrc.2005.02.090","article-title":"Circulating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibility","volume":"329","author":"Tian","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2006.12.006","article-title":"Anatomical differences and atherosclerosis in apolipoprotein E-deficient mice with 129\/SvEv and C57BL\/6 genetic backgrounds","volume":"195","author":"Maeda","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Kayashima, Y., Tomita, H., Zhilicheva, S., Kim, S., Kim, H.S., Bennett, B.J., and Maeda, N. (2014). Quantitative trait loci affecting atherosclerosis at the aortic root identified in an intercross between DBA2J and 129S6 apolipoprotein E-null mice. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0088274"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1161\/01.ATV.0000090126.34881.B1","article-title":"Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL\/6J and FVB\/NJ mice: Comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement)","volume":"23","author":"Teupser","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_99","first-page":"e57556","article-title":"A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes","volume":"139","author":"Yang","year":"2018","journal-title":"J. Vis. Exp."},{"key":"ref_100","first-page":"3116","article-title":"An interspecies study of lipid profiles and atherosclerosis in familial hypercholesterolemia animal models with low-density lipoprotein receptor deficiency","volume":"11","author":"He","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1038\/s41598-023-42763-1","article-title":"Generation of a familial hypercholesterolemia model in non-human primate","volume":"13","author":"Sato","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0006-291X(92)92360-A","article-title":"Hormonal and nutritional stimuli modulate apolipoprotein B mRNA editing in mouse liver","volume":"188","author":"Srivastava","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1074\/jbc.272.3.1456","article-title":"Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice","volume":"272","author":"Oka","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/ATVBAHA.108.169680","article-title":"Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences","volume":"28","author":"Johnson","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"9887","DOI":"10.1074\/jbc.271.17.9887","article-title":"Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48","volume":"271","author":"Hirano","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1161\/hq1001.097780","article-title":"Lipoprotein size and atherosclerosis susceptibility in Apoe-\/- and Ldlr-\/- mice","volume":"21","author":"Veniant","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2174\/1381612826666200218101818","article-title":"Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice","volume":"26","author":"Toth","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1073\/pnas.91.6.2130","article-title":"Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice","volume":"91","author":"Callow","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1172\/JCI118203","article-title":"Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a)","volume":"96","author":"Callow","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00041433-199404000-00005","article-title":"Transgenic mice expressing human apoB100 and apoB48","volume":"5","author":"Young","year":"1994","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1016\/S0021-9258(18)82232-3","article-title":"Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia","volume":"268","author":"Hofker","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"117316","DOI":"10.1016\/j.atherosclerosis.2023.117316","article-title":"Triglyceride content increases while cholesterol content decreases in HDL and LDL+IDL fractions following normal meals: The Copenhagen General Population Study of 25,656 individuals","volume":"383","author":"Johansen","year":"2023","journal-title":"Atherosclerosis"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Chiu, S., Williams, P.T., and Krauss, R.M. (2017). Effects of a very high saturated fat diet on LDL particles in adults with atherogenic dyslipidemia: A randomized controlled trial. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0170664"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.CIR.99.2.276","article-title":"Atherosclerosis in APOE*3-Leiden transgenic mice: From proliferative to atheromatous stage","volume":"99","author":"Lutgens","year":"1999","journal-title":"Circulation"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0021-9150(97)00196-2","article-title":"Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice","volume":"136","author":"Leppanen","year":"1998","journal-title":"Atherosclerosis"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.ATV.0000243925.65265.3c","article-title":"Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice","volume":"26","author":"Westerterp","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e13376","DOI":"10.14814\/phy2.13376","article-title":"Male apoE*3-Leiden.CETP mice on high-fat high-cholesterol diet exhibit a biphasic dyslipidemic response, mimicking the changes in plasma lipids observed through life in men","volume":"5","author":"Paalvast","year":"2017","journal-title":"Physiol. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/ATVBAHA.121.315882","article-title":"Hepatic Scavenger Receptor Class B Type 1 Knockdown Reduces Atherosclerosis and Enhances the Antiatherosclerotic Effect of Brown Fat Activation in APOE*3-Leiden","volume":"41","author":"Zhou","year":"2021","journal-title":"CETP Mice. Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1194\/jlr.M900186-JLR200","article-title":"CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice","volume":"51","author":"Bijland","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCRESAHA.115.304008","article-title":"AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia","volume":"115","author":"Somanathan","year":"2014","journal-title":"Circ. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2016.06.011","article-title":"A single injection of gain-of-function mutant PCSK9 adeno-associated virus vector induces cardiovascular calcification in mice with no genetic modification","volume":"251","author":"Goettsch","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/labinvest.2017.47","article-title":"Accelerated atherosclerosis development in C57Bl6 mice by overexpressing AAV-mediated PCSK9 and partial carotid ligation","volume":"97","author":"Kumar","year":"2017","journal-title":"Lab. Investig."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10741-024-10409-7","article-title":"The role of PCSK9 in heart failure and other cardiovascular diseases-mechanisms of action beyond its effect on LDL cholesterol","volume":"29","author":"Dutka","year":"2024","journal-title":"Heart Fail Rev."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1074\/jbc.M112.421370","article-title":"Low density lipoprotein binds to proprotein convertase subtilisin\/kexin type-9 (PCSK9) in human plasma and inhibits PCSK9-mediated low density lipoprotein receptor degradation","volume":"288","author":"Kosenko","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"909","DOI":"10.5551\/jat.55400","article-title":"An Update on the Role of PCSK9 in Atherosclerosis","volume":"27","author":"Yurtseven","year":"2020","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCRESAHA.115.304351","article-title":"Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing","volume":"115","author":"Ding","year":"2014","journal-title":"Circ. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/ATVBAHA.117.309326","article-title":"CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia","volume":"38","author":"Chadwick","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1194\/jlr.M046540","article-title":"Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia","volume":"55","author":"Wang","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7555\/JBR.28.20140019","article-title":"Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion","volume":"28","author":"Fisher","year":"2014","journal-title":"J. Biomed. Res."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Shi, W., Li, J., Bao, K., Chen, M.H., and Liu, Z. (2022). Ldlr-Deficient Mice with an Atherosclerosis-Resistant Background Develop Severe Hyperglycemia and Type 2 Diabetes on a Western-Type Diet. Biomedicines, 10.","DOI":"10.3390\/biomedicines10061429"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1172\/JCI29950","article-title":"Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata","volume":"117","author":"Swirski","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Sosic-Jurjevic, B., Lutjohann, D., Trifunovic, S., Pavlovic, S., Borkovic Mitic, S., Jovanovic, L., Ristic, N., Marina, L., Ajdzanovic, V., and Filipovic, B. (2023). Differences in Cholesterol Metabolism, Hepato-Intestinal Aging, and Hepatic Endocrine Milieu in Rats as Affected by the Sex and Age. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612624"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1161\/ATVBAHA.118.311513","article-title":"Diet, Microbes, and Murine Atherosclerosis","volume":"38","author":"Getz","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/ATVBAHA.111.238964","article-title":"ApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endothelium","volume":"32","author":"Gaudreault","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1172\/JCI43802","article-title":"Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-\/- mice during disease regression","volume":"121","author":"Potteaux","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCRESAHA.114.302761","article-title":"Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis","volume":"114","author":"Sage","year":"2014","journal-title":"Circ. Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41419-024-07166-8","article-title":"Inflammation in atherosclerosis: Pathophysiology and mechanisms","volume":"15","author":"Ajoolabady","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1194\/jlr.R800058-JLR200","article-title":"Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall","volume":"50","author":"Getz","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/BJ20100016","article-title":"Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms","volume":"428","author":"Zhu","year":"2010","journal-title":"Biochem. J."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Titolo, G., Morello, M., Caiazza, S., Luisi, E., Solimene, A., Serpico, C., D\u2019Elia, S., Golino, P., Loffredo, F.S., and Natale, F. (2025). APOE Genotype and Endothelial Biomarkers: Towards Personalized Cardiovascular Screening. Genes, 16.","DOI":"10.3390\/genes16121494"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1007\/s11357-025-01768-6","article-title":"Immunosenescence accelerates atherosclerosis development in AAV-PCSK9 mouse model","volume":"47","author":"Smit","year":"2025","journal-title":"Geroscience"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"oeac028","DOI":"10.1093\/ehjopen\/oeac028","article-title":"The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction","volume":"2","author":"Keeter","year":"2022","journal-title":"Eur. Heart J. Open"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"44624","DOI":"10.1038\/srep44624","article-title":"Somatic genome editing with CRISPR\/Cas9 generates and corrects a metabolic disease","volume":"7","author":"Jarrett","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Mak, M.C.E., Gurung, R., and Foo, R.S.Y. (2023). Applications of Genome Editing Technologies in CAD Research and Therapy with a Focus on Atherosclerosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241814057"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma","volume":"35","author":"Gibson","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_150","first-page":"805","article-title":"Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and concordant macrophage phenotypes","volume":"2","author":"Rauch","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/ATVBAHA.108.165753","article-title":"CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice","volume":"28","author":"Zhao","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Rentz, T., Dorighello, G.G., Dos Santos, R.R., Barreto, L.M., Freitas, I.N., Lazaro, C.M., Razolli, D.S., Cazita, P.M., and Oliveira, H.C.F. (2023). CETP Expression in Bone-Marrow-Derived Cells Reduces the Inflammatory Features of Atherosclerosis in Hypercholesterolemic Mice. Biomolecules, 13.","DOI":"10.20944\/preprints202307.1930.v1"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"e124574","DOI":"10.1172\/jci.insight.124574","article-title":"Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression","volume":"4","author":"Lin","year":"2019","journal-title":"JCI Insight"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/s41590-020-0768-4","article-title":"Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression","volume":"21","author":"Williams","year":"2020","journal-title":"Nat. Immunol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/eurheartj\/ehu041","article-title":"Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death","volume":"36","author":"Schrijvers","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.ajpath.2011.05.049","article-title":"Prolonged infusion of angiotensin II in apoE-\/- mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm","volume":"179","author":"Rateri","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI7818","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"Daugherty","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/01.CIR.103.3.448","article-title":"Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice","volume":"103","author":"Weiss","year":"2001","journal-title":"Circulation"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Morat, N., Civieri, G., Spezia, M., Menegolo, M., Bernava, G., Iliceto, S., Iop, L., and Tona, F. (2025). Angiotensin II and Atherosclerosis: A New Cardiovascular Risk Factor Beyond Hypertension. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157527"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10557-023-07475-8","article-title":"SR-B1-\/-ApoE-R61h\/h Mice Mimic Human Coronary Heart Disease","volume":"38","author":"Starsichova","year":"2024","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/hh0302.104462","article-title":"Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice","volume":"90","author":"Braun","year":"2002","journal-title":"Circ. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1161\/CIRCULATIONAHA.104.523563","article-title":"Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice","volume":"111","author":"Zhang","year":"2005","journal-title":"Circulation"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"117564","DOI":"10.1016\/j.atherosclerosis.2024.117564","article-title":"The SR-B1DeltaCT\/LDLR KO mouse: A new tool to shed light on coronary artery disease","volume":"395","author":"Ferraro","year":"2024","journal-title":"Atherosclerosis"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"117518","DOI":"10.1016\/j.atherosclerosis.2024.117518","article-title":"Stromal cell-derived factor-1 alpha improves cardiac function in a novel diet-induced coronary atherosclerosis model, the SR-B1DeltaCT\/LDLR KO mouse","volume":"395","author":"Mullis","year":"2024","journal-title":"Atherosclerosis"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/ATVBAHA.114.304200","article-title":"The effects of diet on occlusive coronary artery atherosclerosis and myocardial infarction in scavenger receptor class B, type 1\/low-density lipoprotein receptor double knockout mice","volume":"34","author":"Fuller","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejphar.2017.05.010","article-title":"Animal models of atherosclerosis","volume":"816","author":"Perrotta","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"dmm046565","DOI":"10.1242\/dmm.046565","article-title":"Mouse models of myocardial infarction: Comparing permanent ligation and ischaemia-reperfusion","volume":"13","author":"Riley","year":"2020","journal-title":"Dis. Models Mech."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the vulnerable plaque","volume":"47","author":"Virmani","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","article-title":"Guidelines for experimental models of myocardial ischemia and infarction","volume":"314","author":"Lindsey","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1124\/pharmrev.121.000348","article-title":"Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia\/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning","volume":"75","author":"Ferdinandy","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1172\/JCI117117","article-title":"Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice","volume":"93","author":"Gijbels","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"14152","DOI":"10.1038\/s41598-025-93967-6","article-title":"Artery segmentation and atherosclerotic plaque quantification using AI for murine whole slide images stained with oil red O","volume":"15","author":"Engster","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"21523","DOI":"10.1038\/s41598-020-78632-4","article-title":"Deep learning reveals 3D atherosclerotic plaque distribution and composition","volume":"10","author":"Jurtz","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s44161-026-00827-1","article-title":"Proteomics reveals spatial and molecular heterogeneities in advanced atherosclerotic carotid artery plaques","volume":"5","author":"Sinha","year":"2026","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s44161-024-00582-1","article-title":"Encompassing view of spatial and single-cell RNA sequencing renews the role of the microvasculature in human atherosclerosis","volume":"4","author":"Bleckwehl","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/CIRCRESAHA.120.315930","article-title":"Sex as a Biological Variable in Atherosclerosis","volume":"126","author":"Man","year":"2020","journal-title":"Circ. Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0021-9150(99)00081-7","article-title":"Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice","volume":"145","author":"Caligiuri","year":"1999","journal-title":"Atherosclerosis"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"10022","DOI":"10.1073\/pnas.93.19.10022","article-title":"Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice","volume":"93","author":"Bourassa","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-2275(20)32124-6","article-title":"Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice","volume":"40","author":"Marsh","year":"1999","journal-title":"J. Lipid Res."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.atherosclerosis.2018.09.005","article-title":"AAV8-mediated overexpression of mPCSK9 in liver differs between male and female mice","volume":"278","author":"Vozenilek","year":"2018","journal-title":"Atherosclerosis"}],"container-title":["Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-5354\/13\/8\/911\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:26:00Z","timestamp":1786681560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-5354\/13\/8\/911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":183,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["bioengineering13080911"],"URL":"https:\/\/doi.org\/10.3390\/bioengineering13080911","relation":{},"ISSN":["2306-5354"],"issn-type":[{"value":"2306-5354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}